Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Paul Timperman

Vascular & Interventional Radiology West Lafayette, IN Medical Doctor

NPI 1043279391 CMS profile 319144

253 Sagamore Pkwy W, West Lafayette, IN 47906

Open in the dashboard

General payments

$1,267,097

171 records reported · program years 2019–2025

Research payments

$78,484

Paid to them · 9 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Paul Timperman of West Lafayette, IN is reported in the CMS Open Payments database as having received $1,267,097 across 171 general payments and $78,484 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $97,636 23
2024 General $144,876 20
2023 General $212,766 37
2023 Research $68,900 8
2022 General $229,574 18
2022 Research $9,584 1
2021 General $164,697 20
2020 General $198,700 23
2019 General $218,850 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Timperman
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Paul Timperman were reported at $97,636. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Paul Timperman Vascular & Interventional Radiology median Middle half National median
2019 $218,850 $422 $125–$1,555 $163
2020 $198,700 $200 $68–$652 $114
2021 $164,697 $280 $99–$866 $132
2022 $229,574 $433 $137–$1,497 $149
2023 $212,766 $506 $152–$2,019 $160
2024 $144,876 $556 $175–$1,930 $164
2025 $97,636 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Cook Research Incorporated $1,215,333 113 payments
  2. Cook Incorporated $41,110 10 payments
  3. Cook Medical LLC $8,247 26 payments
  4. Profound Medical Corp. $1,999 2 payments
  5. Medtronic, Inc. $176 9 payments
  6. Endologix, Inc. $39 1 payment
  7. Edwards Lifesciences Corporation $35 2 payments
  8. Cardiovascular Systems Inc. $32 1 payment
  9. Medtronic Vascular, Inc. $31 2 payments
  10. MF Med $30 1 payment
  11. Other $66 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $1,256,443 123 payments
  2. Travel and Lodging $8,925 14 payments
  3. Food and Beverage $1,730 34 payments
Products named General payments · program years 2019–2025
  1. COOK Peripheral Intervention $3,594 7 payments
  2. Cook Interventional Radiology $3,258 1 payment
  3. Tulsa-Pro $1,999 2 payments
  4. PROFUSION THERAPEUTIC INFUSION NEEDLE $1,312 14 payments
  5. VENASEAL $114 6 payments
  6. Ovation $39 1 payment
  7. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $35 2 payments
  8. Diamondback Peripheral $32 1 payment
  9. Concerto $31 2 payments
  10. ClosureFast $25 1 payment
  11. Other $124 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Cook Incorporated $68,900 8 payments
  2. Cook Biotech Incorporated $9,584 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Diagnostic Radiology: 24

Drug cost

$7

Median for Diagnostic Radiology: $190

Branded share of claims

0%

Median for Diagnostic Radiology: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Alprazolam Generic 12 $7

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,198 Part D prescribers listed as Diagnostic Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 102 billing codes

Paid by Medicare

$49,857

Of which drugs: $200

Medicare patients

511

Average age 74

Services billed

2,484

286 women, 225 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Chronic kidney disease 43%
Diabetes 37%
Depression 34%
Ischemic heart disease 32%
COPD 28%
Heart failure 27%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 18 1,422 $148

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

180 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record